Today studies targeting disease- specific molecular markers regulation using AGL need attention; e.g., Cordon-bleu protein like-1 (COBLL1) serves as a molecular marker for the patient’s overall survival in chronic lymphocytic leukemia (CLL) and its AGL-induced possible modulation might benefit CLL therapy [30]. The gene discussed is AGL; the disease is B-cell chronic lymphocytic leukemia.